NeOnc Technologies Holdings is trading 7.11% higher in pre-market at $2.71 on October 9; no confirmed company announcement dated October 9 explains the move. - The prior session closed at $2.53, according to the supplied price context. - Recent coverage discusses upcoming FDA meetings, including a November 17 meeting for NEO212, rather than a new catalyst today. - The supplied market snapshot is modestly positive but does not establish broader market sentiment as the cause of the stock-specific gain.